Tuberculosis
3 trials
TB-PRACTECAL
2022
Short All-Oral Regimens for Rifampicin-Resistant TB
ZeNix
2022
Bedaquiline-Pretomanid-Linezolid Regimens for MDR/XDR-TB
Study 31 / A5349
2021
Four-Month Rifapentine-Based Regimen for Drug-Susceptible TB